Bristol Myers Squibb Co. (BMY)

60.48 +0.18 (+0.30%) USD  |  NYSE  |  Feb 20, 12:19
More

Bristol Myers Squibb Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Amgen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Janux Therapeutics, Inc. Upgrade